Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer
Comparative Analysis of the Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Conventional Open Thyroidectomy
1 other identifier
observational
400
0 countries
N/A
Brief Summary
In general, the utilization of the transoral vestibular approach in robotic surgery demonstrates efficacy comparable to that of traditional open surgery in the treatment of thyroid cancer. This method not only reduces the length of hospitalization for patients but also ensures superior cosmetic outcomes in the cervical region, thus achieving truly scarless aesthetics. The feasibility of Transoral Vestibular Robotic Thyroidectomy (TOVRT) for tumors greater than 2 cm in diameter warrants further exploration in future studies; however, for tumors less than 2 cm in diameter, TOVRT emerges as a safe, reliable, and practical alternative, poised to establish itself as an innovative surgical modality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedFirst Posted
Study publicly available on registry
May 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedMay 6, 2025
April 1, 2025
1 month
April 6, 2025
April 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Key Observational Indicators
Incidental parathyroidectomy rate
6moths
Secondary Outcomes (1)
Secondary observations
6months
Other Outcomes (1)
Other Pre-Specified Outcome
6moths
Study Arms (2)
traditional open group
1\) General demographic information: including age, gender, ethnicity, etc. 2) Disease-related information: lesion size, lesion location, pathological type, parathyroid function (preoperative, first day postoperative, and one week postoperative), thyroid function (preoperative and one month postoperative), etc.3) Surgery-related information: occurrence of postoperative complications, total number of days of hospitalization following the operation, postoperative quality of life (dysphagia index, neck injury index), etc.
robotic group
1\) General demographic information: including age, gender, ethnicity, etc. 2) Disease-related information: lesion size, lesion location, pathological type, parathyroid function (preoperative, first day postoperative, and one week postoperative), thyroid function (preoperative and one month postoperative), etc.3) Surgery-related information: occurrence of postoperative complications, total number of days of hospitalization following the operation, postoperative quality of life (dysphagia index, neck injury index), etc.
Interventions
Effectiveness of different surgical modalities in the treatment of thyroid cancer
Eligibility Criteria
Thyroid cancer patients
You may qualify if:
- Age 18- 65 years old, both male and female
- Postoperative pathology was papillary thyroid carcinoma
- Clinical data integrity
You may not qualify if:
- Postoperative pathology was benign
- Clinical data are incomplete
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2025
First Posted
May 6, 2025
Study Start
May 1, 2025
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
May 6, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share